The University of Oxford’s Covid-19 vaccine trial has only a 50% chance of success as the coronavirus seems to be fading rapidly in Britain, the professor co-leading the development of the vaccine has said.Oxford’s Jenner Institute has tied up with biopharma major AstraZeneca Plc to produce the vaccine on a mass scale if the results are successful.The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus causing the coronavirus pandemic.The upcoming trial, involving 10,000 volunteers, threatened to return “no result” due to low transmission of Covid-19 in the community, Adrian Hill, director of the Jenner Institute, said.“It’s a race against the virus disappearing, and against time. At the moment, there’s a 50% chance that we get no result at all,” Hill said while speaking to the British newspaper, the Telegraph.Hill’s team began early-stage human trials of the vaccine in April, making it one of a handful to have reached that milestone.Earlier this week, the developers of the vaccine had described their efforts as progressing “very well”, moving to the next phase after completing 1,000 immunisations by its candidate-vaccine on healthy human adults.The next… Read full this story
- On a mission: Redditch woman’s bid to help further vaccine trial
- New implant, vaccine trial offer fresh HIV hope
- Pocock better than '50-50' chance of playing World Cup
- 'Extinct' volcano has 50/50 chance of erupting
- Man tells modern slavery trial he was 'petrified'
- Indonesia condemns political exile's Oxford honour
- 'Jihadi Jack' parents' trial 'inhumane'
- Oxford University's £4bn housing plan
- One in four Oxford places set for poorest students by 2023
- 'Jihadi Jack' parents trial jury retires
Oxford’s Covid-19 vaccine trial has 50% chance of success: Project leader have 285 words, post on www.hindustantimes.com at May 24, 2020. This is cached page on Vietnam Colors. If you want remove this page, please contact us.